O26.642

Clinical Causes: Hormonal changes during pregnancy, especially increased levels of estrogen and progesterone, can impair bile flow. Genetic predisposition, as family history may increase risk. Liver disorders or previous liver disease may contribute to the development of ICP. Environmental factors and certain medications can influence bile production and flow. Increased levels of bile acids due to intrahepatic cholestasis cause the characteristic symptoms and potential complications.

Key Symptoms: Intense, persistent itching, particularly on the palms of the hands and soles of the feet. Dark urine due to excess bile pigments. Pale-colored stools resulting from decreased bile flow. Jaundice, or yellowing of the skin and eyes, in some cases. May experience fatigue, loss of appetite, or nausea. Occasionally, there might be swelling or tenderness in the right upper abdomen.

Diagnosis Path: Serum bile acid levels: Elevated levels are a hallmark of intrahepatic cholestasis. Liver function tests: To assess liver health and identify any damage or abnormalities. Serum bilirubin levels: May be increased in some cases. Additional tests may include ultrasound imaging to rule out other liver conditions or obstructions.

Treatment Protocols: Medications such as ursodeoxycholic acid to help improve bile flow and reduce bile acid levels. Regular monitoring of bile acid levels and liver function tests to track the progress. Antihistamines may be prescribed to help control severe itching. Lifestyle modifications, including avoiding irritants or foods that may exacerbate symptoms. Frequent fetal assessments, such as non-stress tests and ultrasounds, to monitor fetal wellbeing. In some cases, early delivery might be recommended if the risks outweigh the benefits of continuing the pregnancy.